These researchers sought to determine if ethnic disparities in treatment and survival exist among a cohort of Māori (n=344) and non-Māori women (n=1567) with cervical cancer (adenocarcinoma, adenosquamous or squamous cell carcinoma) who were retrospectively identified from the New Zealand Cancer Register between 1 January 1996 and 31 December 2006. Inequalities in incidence and mortality decreased over time. Over the cohort period, Māori women were more likely to have poorer cancer-specific survival than non-Māori women (mortality hazard ratio 2.07). However, from 1996 to 2005, the survival for Māori improved significantly relative to non-Māori. Māori women with cervical cancer had a higher receipt of total hysterectomies, and similar receipt of radical hysterectomies and brachytherapy as primary treatment, compared to non-Māori women (age and stage adjusted).
